Бериплекс P/N

Бериплекс P/N is a human coagulation factor complex used to support blood clotting processes. This intravenous therapy helps manage bleeding disorders and related conditions. A trusted option for coagulation support in clinical settings. Suitable for patients requiring factor replacement.

Бериплекс P/N is used to treat and prevent bleeding episodes in patients with congenital or acquired deficiencies of coagulation factors. It supports hemostasis by providing essential clotting proteins like Factor IX, Factor VII, Protein C, and Protein S. This medication is particularly useful in managing conditions such as hemophilia B or other bleeding disorders where natural clotting is impaired. It may also be used perioperatively to reduce bleeding risk during surgical procedures.

After administration, Бериплекс P/N helps restore normal clotting function by replenishing missing or deficient coagulation factors. Patients may experience improved blood clotting and reduced bleeding tendencies. The effects vary depending on the underlying condition and individual response. Regular monitoring is recommended to assess therapeutic outcomes.

Store Бериплекс P/N as directed, typically refrigerated but not frozen, to maintain potency. Protect from light and moisture. Always check the product for discoloration or particles before use. Follow healthcare provider instructions for handling and disposal. Keep out of reach of children and pets. Report any adverse reactions to a medical professional promptly.

Concomitant use with anticoagulants or fibrinolytic agents may alter the effects of Бериплекс P/N. Avoid mixing with other medications unless approved by a healthcare provider. Alcohol and certain herbal supplements may interfere with clotting function. Always inform your doctor about all medications and supplements you are taking to prevent potential interactions.